首页> 外文OA文献 >Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies

【2h】

Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies

机译：与BCL2抑制剂venetoclax的临床经验在联合治疗中复发和难治性急性髓性白血病和相关霉菌性恶性肿瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Courtney D. DiNardo; Caitlin R. Rausch; Christopher Benton; Tapan Kadia; Nitin Jain; Naveen Pemmaraju; Naval Daver; Wendy Covert; Kayleigh R. Marx; Morgan Mace; Elias Jabbour; Jorge Cortes; Guillermo Garcia-Manero; Farhad Ravandi; Kapil N. Bhalla; Hagop Kantarjian; Marina Konopleva;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical experience with the BCL BCL 2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies [J] . DiNardo Courtney D., Rausch Caitlin R., Benton Christopher, American Journal of Hematology . 2018,第3期

机译：与BCL BCL 2抑制剂venetoclax的临床经验在联合治疗中复发和难治性急性髓性白血病和相关霉菌性恶性肿瘤
2. Venetoclax combination therapy in relapsed/refractory acute myeloid leukemia: A single institution experience [J] . Gaut Daria, Burkenroad Aaron, Duong Tuyen, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2020,第期

机译：威尼柯克斗组合治疗复发/难治性急性髓性白血病：单一机构经验
3. Clinical Experience of Venetoclax Combinations for Relapsed/Refractory Myeloid Malignancies [J] . Caitlin R. Rausch, Courtney D. DiNardo, Tapan Kadia, Clinical lymphoma, myeloma & leukemia . 2017,第10期

机译：威尼索克克克斯复发/难治性骨髓性恶性肿瘤的临床经验组合
4. Computationally derived cytological image markers for predicting risk of relapse in acute myeloid leukemia patients following bone marrow transplantation [C] . Sara ArabYarmohammadi, Zelin Zhang, Patrick Leo, Conference on Medical Imaging: Digital Pathology . 2020

机译：计算源自骨髓移植后急性髓性白血病患者复发风险的细胞学图像标志物
5. Loss of Egr1 plays a role in murine leukemogenesis and may play a role in the development of acute myeloid leukemia and therapy-related acute myeloid leukemia. [D] . Joslin, John M. 2006

机译：Egr1的丢失在小鼠白血病的发生中起作用，并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
6. Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies [O] . Jonathan Feld, Douglas Tremblay, Mikaela Dougherty, 2021

机译：安全性和疗效：威尼妥葡萄糖的临床经验与新诊断和复发/难治晚期骨髓恶性肿瘤的低甲基化试剂组合
7. Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis [O] . 2020

机译：威尼柯克斯作为单药治疗，并与低甲基化试剂或低剂量的令人难以染色的急性髓性白血病：系统评价和荟萃分析

Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies

著录项

引文网络

相似文献

相关主题

期刊订阅